SOMATROGON-GHLA

SOMATROGON-GHLA was reported 1247 times

These side effects are most commonly reported by patients taking SOMATROGON-GHLA:

# Side effect Count
0 INJECTION SITE PAIN 805
1 WRONG TECHNIQUE IN DEVICE USAGE PROCESS 49
2 INJECTION SITE ERYTHEMA 48
3 INCORRECT DOSE ADMINISTERED BY DEVICE 47
4 DRUG DOSE OMISSION BY DEVICE 43
5 INJECTION SITE SWELLING 40
6 HEADACHE 38
7 DEVICE MECHANICAL ISSUE 36
8 NEEDLE ISSUE 36
9 DEVICE DELIVERY SYSTEM ISSUE 33
10 PATIENT-DEVICE INCOMPATIBILITY 33
11 OFF LABEL USE 32
12 DEVICE LEAKAGE 28
13 INCORRECT DOSE ADMINISTERED 27
14 INJECTION SITE MASS 27
15 DEVICE ISSUE 21
16 INJECTION SITE HAEMORRHAGE 21
17 INJECTION SITE PRURITUS 21
18 PRODUCT DOSE OMISSION ISSUE 21
19 INJECTION SITE BRUISING 19
20 PRODUCT COMMUNICATION ISSUE 19
21 CRYING 18
22 VOMITING 18
23 DRUG INEFFECTIVE 16
24 DEVICE DIFFICULT TO USE 15
25 ANXIETY 14
26 INJECTION SITE DISCOMFORT 14
27 INJURY ASSOCIATED WITH DEVICE 14
28 EXPOSURE VIA SKIN CONTACT 13
29 LIPODYSTROPHY ACQUIRED 13
30 PAIN 13
31 PYREXIA 13
32 WEIGHT INCREASED 13
33 DEVICE BREAKAGE 12
34 DIZZINESS 12
35 FEAR OF INJECTION 12
36 LACK OF INJECTION SITE ROTATION 12
37 NAUSEA 12
38 SEIZURE 12
39 ACCIDENTAL EXPOSURE TO PRODUCT 10
40 DEVICE DEFECTIVE 10
41 INJECTION SITE DISCHARGE 10
42 INJECTION SITE RASH 10
43 PAIN IN EXTREMITY 10
44 POOR QUALITY DEVICE USED 10
45 RASH 10
46 DEVICE PHYSICAL PROPERTY ISSUE 9
47 FATIGUE 9
48 SYNCOPE 9
49 INJECTION SITE REACTION 8
50 PRODUCT PRESCRIBING ERROR 8
51 DEVICE USE ERROR 7
52 ERYTHEMA 7
53 PNEUMONIA 7
54 PRODUCT CONTAMINATION 7
55 PUNCTURE SITE HAEMORRHAGE 7
56 ABDOMINAL PAIN 6
57 ABDOMINAL PAIN UPPER 6
58 ARTHRALGIA 6
59 DEVICE MALFUNCTION 6
60 DEVICE MATERIAL ISSUE 6
61 HYPOGLYCAEMIA 6
62 INTENTIONAL PRODUCT MISUSE 6
63 URTICARIA 6
64 ABNORMAL BEHAVIOUR 5
65 DEVICE OCCLUSION 5
66 DEVICE USE ISSUE 5
67 DIARRHOEA 5
68 EPIPHYSIOLYSIS 5
69 FEELING ABNORMAL 5
70 INFLUENZA 5
71 INJECTION SITE ATROPHY 5
72 INTRACRANIAL PRESSURE INCREASED 5
73 MALAISE 5
74 PAPILLOEDEMA 5
75 PRURITUS 5
76 SCREAMING 5
77 UNDERDOSE 5
78 AGGRESSION 4
79 ASTHENIA 4
80 CONDITION AGGRAVATED 4
81 COUGH 4
82 DEVICE DEPLOYMENT ISSUE 4
83 DRUG HYPERSENSITIVITY 4
84 DRY SKIN 4
85 EPILEPSY 4
86 HUNGER 4
87 ILLNESS 4
88 INCREASED APPETITE 4
89 INJECTION SITE INDURATION 4
90 INJECTION SITE INFLAMMATION 4
91 INSOMNIA 4
92 INSULIN-LIKE GROWTH FACTOR DECREASED 4
93 MIGRAINE 4
94 MOOD ALTERED 4
95 NASAL CONGESTION 4
96 OEDEMA PERIPHERAL 4
97 PATIENT-DEVICE INTERACTION ISSUE 4
98 POOR QUALITY PRODUCT ADMINISTERED 4
99 PRODUCT ADMINISTERED AT INAPPROPRIATE SITE 4
100 PRODUCT ODOUR ABNORMAL 4
101 SWELLING 4
102 WEIGHT DECREASED 4
103 ACCIDENTAL UNDERDOSE 3
104 ADRENOCORTICAL INSUFFICIENCY ACUTE 3
105 AGITATION 3
106 DEPRESSED MOOD 3
107 DYSGEUSIA 3
108 EMOTIONAL DISORDER 3
109 EOSINOPHIL COUNT INCREASED 3
110 FLUID RETENTION 3
111 GAIT DISTURBANCE 3
112 GASTROENTERITIS VIRAL 3
113 GROWTH RETARDATION 3
114 HYPERSENSITIVITY 3
115 INJECTION SITE URTICARIA 3
116 INSULIN-LIKE GROWTH FACTOR INCREASED 3
117 NASOPHARYNGITIS 3
118 NEOPLASM MALIGNANT 3
119 OEDEMA 3
120 PANIC ATTACK 3
121 PRODUCT PRESCRIBING ISSUE 3
122 SCRATCH 3
123 VIRAL INFECTION 3
124 WRONG TECHNIQUE IN PRODUCT USAGE PROCESS 3
125 ADRENAL INSUFFICIENCY 2
126 APPETITE DISORDER 2
127 ASTHMA 2
128 AUTISM SPECTRUM DISORDER 2
129 BACK PAIN 2
130 BLINDNESS 2
131 BLOOD GROWTH HORMONE INCREASED 2
132 BLOOD PROLACTIN INCREASED 2
133 BRONCHITIS 2
134 CHEST PAIN 2
135 CLAVICLE FRACTURE 2
136 CONSTIPATION 2
137 CONTUSION 2
138 CORTISOL INCREASED 2
139 CUSHING^S SYNDROME 2
140 DEAFNESS 2
141 DEATH 2
142 DECREASED APPETITE 2
143 DEPRESSION 2
144 DISEASE PROGRESSION 2
145 DRUG INTOLERANCE 2
146 DYSGRAPHIA 2
147 DYSPHAGIA 2
148 DYSPNOEA 2
149 EAR INFECTION 2
150 EPISTAXIS 2
151 EXTRA DOSE ADMINISTERED 2
152 FACIAL PARALYSIS 2
153 GUILLAIN-BARRE SYNDROME 2
154 HEART RATE INCREASED 2
155 HOT FLUSH 2
156 HYPERHIDROSIS 2
157 HYPERTROPHY 2
158 INAPPROPRIATE SCHEDULE OF PRODUCT ADMINISTRATION 2
159 INFLUENZA LIKE ILLNESS 2
160 INJECTION SITE HAEMATOMA 2
161 INJECTION SITE HYPERSENSITIVITY 2
162 INJECTION SITE HYPOAESTHESIA 2
163 LOSS OF CONSCIOUSNESS 2
164 MELANOCYTIC NAEVUS 2
165 MENTAL DISORDER 2
166 MIDDLE INSOMNIA 2
167 NEGATIVE THOUGHTS 2
168 NO ADVERSE EVENT 2
169 OBSESSIVE-COMPULSIVE DISORDER 2
170 OPTIC NEUROPATHY 2
171 OROPHARYNGEAL PAIN 2
172 PERIORBITAL SWELLING 2
173 PRODUCT CONTAMINATION PHYSICAL 2
174 PRODUCT DOSE OMISSION IN ERROR 2
175 PRODUCT KNOWLEDGE DEFICIT 2
176 PRODUCT USE ISSUE 2
177 RESPIRATORY RATE INCREASED 2
178 RHINORRHOEA 2
179 SOMNOLENCE 2
180 STATUS EPILEPTICUS 2
181 THERAPEUTIC RESPONSE SHORTENED 2
182 THERAPY INTERRUPTED 2
183 THIRST 2
184 TINNITUS 2
185 TREATMENT NONCOMPLIANCE 2
186 TREMOR 2
187 VISION BLURRED 2
188 WHEEZING 2
189 ABDOMINAL DISCOMFORT 1
190 ABDOMINAL DISTENSION 1
191 ABDOMINAL MASS 1
192 ACCIDENTAL OVERDOSE 1
193 ACNE 1
194 ACRAL OVERGROWTH 1
195 ACROCHORDON 1
196 ACUTE LYMPHOCYTIC LEUKAEMIA 1
197 ADENOTONSILLECTOMY 1
198 ADMINISTRATION SITE RASH 1
199 ADRENOCORTICOTROPIC HORMONE DEFICIENCY 1
200 AIDS RELATED COMPLEX 1
201 AMYOTROPHY 1
202 ANAPHYLACTIC REACTION 1
203 ANGER 1
204 APPENDICITIS 1
205 APPENDICITIS PERFORATED 1
206 APPLICATION SITE PAIN 1
207 ARNOLD-CHIARI MALFORMATION 1
208 ARTERIOSCLEROSIS CORONARY ARTERY 1
209 ARTHRITIS 1
210 BITE 1
211 BLOOD CALCIUM INCREASED 1
212 BLOOD CREATININE INCREASED 1
213 BLOOD FOLLICLE STIMULATING HORMONE DECREASED 1
214 BLOOD GLUCOSE INCREASED 1
215 BLOOD IMMUNOGLOBULIN A INCREASED 1
216 BLOOD INSULIN INCREASED 1
217 BLOOD TEST ABNORMAL 1
218 BLOOD THYROID STIMULATING HORMONE INCREASED 1
219 BODY TEMPERATURE ABNORMAL 1
220 BONE DENSITY ABNORMAL 1
221 BONE PAIN 1
222 BREAST ENLARGEMENT 1
223 BREATH ODOUR 1
224 CARDIAC NEOPLASM UNSPECIFIED 1
225 CHOLECYSTECTOMY 1
226 CIRCUMSTANCE OR INFORMATION CAPABLE OF LEADING TO DEVICE USE ERROR 1
227 CIRCUMSTANCE OR INFORMATION CAPABLE OF LEADING TO MEDICATION ERROR 1
228 COMA 1
229 COVID-19 1
230 CRITICAL ILLNESS 1
231 CULTURE POSITIVE 1
232 CYANOSIS 1
233 DEHYDRATION 1
234 DELIRIUM 1
235 DEPENDENCE ON OXYGEN THERAPY 1
236 DERMATITIS ALLERGIC 1
237 DEVICE CONNECTION ISSUE 1
238 DEVICE LOOSENING 1
239 DEVICE RELATED INFECTION 1
240 DEVICE USE CONFUSION 1
241 DIABETES INSIPIDUS 1
242 DIPLOPIA 1
243 DISCOMFORT 1
244 DISEASE RECURRENCE 1
245 DRUG EFFECT LESS THAN EXPECTED 1
246 DRUG INTERACTION 1
247 DRY EYE 1
248 DYSKINESIA 1
249 EAR PAIN 1
250 EMOTIONAL DISTRESS 1
251 ENLARGED CLITORIS 1
252 EOSINOPHIL PERCENTAGE INCREASED 1
253 EOSINOPHILIA 1
254 EPHELIDES 1
255 ERYTHEMA MULTIFORME 1
256 EXCESSIVE GRANULATION TISSUE 1
257 EXPOSURE TO CONTAMINATED DEVICE 1
258 EXPOSURE VIA EYE CONTACT 1
259 EXTREMITY CONTRACTURE 1
260 FACE OEDEMA 1
261 FEELING HOT 1
262 FLUSHING 1
263 FOCAL PERITONITIS 1
264 FOREIGN BODY IN SKIN OR SUBCUTANEOUS TISSUE 1
265 FRACTURE 1
266 FUNGAL INFECTION 1
267 GAIT INABILITY 1
268 GALLBLADDER OPERATION 1
269 GASTRIC INFECTION 1
270 GASTROINTESTINAL DISORDER 1
271 GASTROINTESTINAL INFECTION 1
272 GOITRE 1
273 GREY MATTER HETEROTOPIA 1
274 GROWTH FAILURE 1
275 HAEMATEMESIS 1
276 HAEMATURIA 1
277 HAEMOGLOBINURIA 1
278 HAEMORRHAGE 1
279 HAIR GROWTH ABNORMAL 1
280 HAND-FOOT-AND-MOUTH DISEASE 1
281 HEAD BANGING 1
282 HEART RATE ABNORMAL 1
283 HEART RATE DECREASED 1
284 HEAT EXHAUSTION 1
285 HYPERINSULINAEMIA 1
286 HYPERTHERMIA 1
287 HYPERTHYROIDISM 1
288 HYPOPITUITARISM 1
289 HYPOTHYROIDISM 1
290 HYPOTONIA 1
291 IDIOPATHIC INTRACRANIAL HYPERTENSION 1
292 IMPAIRED GASTRIC EMPTYING 1
293 INCORRECT DOSE ADMINISTERED BY PRODUCT 1
294 INCORRECT ROUTE OF PRODUCT ADMINISTRATION 1
295 INFECTION 1
296 INFLAMMATION 1
297 INFREQUENT BOWEL MOVEMENTS 1
298 INFUSION RELATED REACTION 1
299 INFUSION SITE BRUISING 1
300 INFUSION SITE DISCHARGE 1
301 INFUSION SITE IRRITATION 1
302 INFUSION SITE OEDEMA 1
303 INFUSION SITE PAIN 1
304 INITIAL INSOMNIA 1
305 INJECTION SITE DISCOLOURATION 1
306 INJECTION SITE EXFOLIATION 1
307 INJECTION SITE HYPERTROPHY 1
308 INJECTION SITE PARAESTHESIA 1
309 INJECTION SITE SCAR 1
310 INJECTION SITE VESICLES 1
311 INJECTION SITE WARMTH 1
312 INSULIN RESISTANT DIABETES 1
313 INSURANCE ISSUE 1
314 INTENTIONAL DOSE OMISSION 1
315 INTESTINAL RESECTION 1
316 IRRITABILITY 1
317 JOINT INJURY 1
318 JOINT INSTABILITY 1
319 JOINT RANGE OF MOTION DECREASED 1
320 KETOSIS 1
321 KIDNEY SMALL 1
322 KNEE OPERATION 1
323 LACK OF ADMINISTRATION SITE ROTATION 1
324 LACRIMATION INCREASED 1
325 LARYNGEAL STENOSIS 1
326 LETHARGY 1
327 LEUKAEMIA 1
328 LEUKOPENIA 1
329 LIMB ASYMMETRY 1
330 LIMB MASS 1
331 LIPOATROPHY 1
332 LIPOMA 1
333 LIQUID PRODUCT PHYSICAL ISSUE 1
334 LOSS OF PERSONAL INDEPENDENCE IN DAILY ACTIVITIES 1
335 LOWER RESPIRATORY TRACT INFECTION 1
336 MACULE 1
337 MALNUTRITION 1
338 MAMMOGRAM ABNORMAL 1
339 MASS 1
340 MATERNAL EXPOSURE DURING PREGNANCY 1
341 MEAN CELL HAEMOGLOBIN DECREASED 1
342 MEAN PLATELET VOLUME INCREASED 1
343 MEDICAL DEVICE DISCOMFORT 1
344 MEDICAL DEVICE SITE DISCHARGE 1
345 MEDICAL DEVICE SITE INFECTION 1
346 MENINGITIS 1
347 MENTAL IMPAIRMENT 1
348 METASTASES TO BONE MARROW 1
349 MILIARIA 1
350 MOBILITY DECREASED 1
351 MONOCYTE PERCENTAGE INCREASED 1
352 MOOD SWINGS 1
353 MORAXELLA INFECTION 1
354 MOUTH HAEMORRHAGE 1
355 MUSCLE HYPERTROPHY 1
356 MUSCLE INJURY 1
357 MUSCLE SPASMS 1
358 MUSCLE TWITCHING 1
359 MUSCULAR WEAKNESS 1
360 MUSCULOSKELETAL STIFFNESS 1
361 MYALGIA 1
362 MYDRIASIS 1
363 MYOCARDIAL INFARCTION 1
364 MYOCLONUS 1
365 MYOPIA 1
366 NAEVUS HAEMORRHAGE 1
367 NASAL DISCHARGE DISCOLOURATION 1
368 NASAL POLYPS 1
369 NECK PAIN 1
370 NEPHROTIC SYNDROME 1
371 NERVOUSNESS 1
372 NEUROBLASTOMA RECURRENT 1
373 NEUROLOGICAL EXAMINATION ABNORMAL 1
374 NEUTROPENIA 1
375 NEUTROPHIL COUNT DECREASED 1
376 NEUTROPHIL PERCENTAGE DECREASED 1
377 OBSTRUCTIVE SLEEP APNOEA SYNDROME 1
378 OPHTHALMOLOGICAL EXAMINATION ABNORMAL 1
379 OROPHARYNGEAL DISCOMFORT 1
380 ORTHOSTATIC HYPOTENSION 1
381 OVERDOSE 1
382 PALLOR 1
383 PANCREATITIS 1
384 PARTIAL SEIZURES 1
385 PETECHIAE 1
386 PETIT MAL EPILEPSY 1
387 PHARYNGEAL INFLAMMATION 1
388 PHARYNGEAL SWELLING 1
389 PHOTOSENSITIVITY REACTION 1
390 PINEAL GLAND CYST 1
391 PITUITARY STALK INTERRUPTION SYNDROME 1
392 PNEUMOCOCCAL INFECTION 1
393 PNEUMONIA MYCOPLASMAL 1
394 PNEUMONIA PNEUMOCOCCAL 1
395 PNEUMONIA STAPHYLOCOCCAL 1
396 PNEUMONIA VIRAL 1
397 POLYURIA 1
398 PRECOCIOUS PUBERTY 1
399 PRESCRIBED UNDERDOSE 1
400 PRESYNCOPE 1
401 PRODUCT ADMINISTRATION ERROR 1
402 PRODUCT ADMINISTRATION INTERRUPTED 1
403 PRODUCT COMPLAINT 1
404 PRODUCT LEAKAGE 1
405 PRODUCT NAME CONFUSION 1
406 PRODUCT SELECTION ERROR 1
407 PRODUCT STORAGE ERROR 1
408 PRODUCT SUBSTITUTION ISSUE 1
409 PRODUCTIVE COUGH 1
410 PROTEIN-LOSING GASTROENTEROPATHY 1
411 PSEUDOMONAS INFECTION 1
412 PSYCHOLOGICAL TRAUMA 1
413 PYELONEPHRITIS 1
414 RASH ERYTHEMATOUS 1
415 RASH PRURITIC 1
416 REACTION TO PRESERVATIVES 1
417 RECTAL FISSURE 1
418 REFUSAL OF TREATMENT BY PATIENT 1
419 RENAL ATROPHY 1
420 RENAL FAILURE 1
421 RENAL IMPAIRMENT 1
422 RESPIRATORY TRACT INFECTION 1
423 RHINOVIRUS INFECTION 1
424 SEPSIS 1
425 SEPTIC SHOCK 1
426 SEPTO-OPTIC DYSPLASIA 1
427 SHORT STATURE 1
428 SINUS DISORDER 1
429 SKIN DISORDER 1
430 SKIN HYPERPIGMENTATION 1
431 SKIN LESION 1
432 SLEEP APNOEA SYNDROME 1
433 SLEEP DISORDER 1
434 SLEEP DISORDER DUE TO A GENERAL MEDICAL CONDITION 1
435 SNEEZING 1
436 SPINAL CORD OEDEMA 1
437 SPONTANEOUS HAEMATOMA 1
438 STAPHYLOCOCCAL INFECTION 1
439 STREPTOCOCCAL INFECTION 1
440 SUICIDAL BEHAVIOUR 1
441 SUICIDAL IDEATION 1
442 SUSPECTED COVID-19 1
443 SUSPECTED OFF LABEL USE 1
444 SWELLING FACE 1
445 SYRINGE ISSUE 1
446 SYRINGOMYELIA 1
447 TEARFULNESS 1
448 TENSION 1
449 THERAPEUTIC PRODUCT EFFECT DECREASED 1
450 THERAPEUTIC PRODUCT EFFECT INCOMPLETE 1
451 THERAPY CESSATION 1
452 THYROID DISORDER 1
453 THYROXINE INCREASED 1
454 TONSILLAR HYPERTROPHY 1
455 TURNER^S SYNDROME 1
456 TYPE 1 DIABETES MELLITUS 1
457 UPPER LIMB FRACTURE 1
458 UPPER RESPIRATORY TRACT CONGESTION 1
459 UPPER RESPIRATORY TRACT INFECTION 1
460 URETHRAL OPERATION 1
461 URINARY TRACT INFECTION 1
462 VASCULAR DEVICE INFECTION 1
463 VASCULAR INJURY 1
464 VEIN RUPTURE 1
465 VERTIGO 1
466 VITREOUS FLOATERS 1
467 WEIGHT LOSS POOR 1
468 WOUND INFECTION STAPHYLOCOCCAL 1
469 WRONG DOSE 1
470 WRONG PRODUCT ADMINISTERED 1